109622 ⎘
dsDNA viruses; Details; Adenoviridae; Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Methods of Targeting Mutant Cells
#2STABILIZATION OF VIRUS-BASED THERAPEUTIC AGENT
#3PREPARATION METHOD FOR ADENOVIRUS P53-LOADED DENDRITIC CELL VACCINE
#4METHOD FOR RELEASING VIRAL VECTORS
#5Paracrine Adenoviral Delivery of Biomolecules
#6ERYTHROID LINEAGES DERIVED FROM PLURIPOTENT CELLS
#7Enhanced adoptive cell therapy
#8NUCLEIC ACIDS ENCODING HUMAN ENDOGENOUS RETROVIRUS K (HERV-K) ENVELOPE PROTEINS CONTAINING MODIFIED IMMUNOSUPPRESSIVE DOMAINS (ISD) AND USES THEREOF
#9MESENCHYMAL PROGENITOR CELLS FOR ENHANCING PARTIAL REPROGRAMMING OF TARGET CELLS
#10Adenoviral-Based In Situ Delivery of Bispecific T Cell Engagers
#11A REPLICATIVE ONCOLYTIC ADENOVIROUS CAPABLE OF INHIBITING TUMOR PROGRESSION AND PROLONGING SURVIVAL TIME IN TUMOR-BEARING INDIVIDUALS AND USE THEREOF
#12IL-2 SUPERAGONISTS IN COMBINATION WITH ANTI-PD-1 ANTIBODIES
#13METHODS AND MATERIALS FOR PROMOTING BONE GROWTH
#14IMPROVED IGG-DEGRADING ENZYMES AND METHODS OF USE THEREOF
#15NEDDYLATION-ACTIVATING ENZYME INHIBITORS AS VIRAL SENSITIZERS AND USES THEREOF
#16METHODS OF PRODUCING RECOMBINANT ADENOVIRUS VECTORS
#17CONSTRUCTS FOR ENHANCING IMMUNE RESPONSES
#18EXOGENOUS GENE EXPRESSION IN RECOMBINANT ADENOVIRUS FOR MINIMAL IMPACT ON VIRAL KINETICS
#19IMMUNE-CLOAKING ANTITUMOR ADENOVIRUS
#20ADENOVIRAL VECTORS
#21Adenoviral Vectors Comprising Partial Deletions of E3
#22METHOD FOR THE MANUFACTURE OF RECOMBINANT ADENOVIRUS VECTORS
#23ADENOVIRAL VECTOR-BASED VACCINE FOR EMERGING VIRUSES
#24HEPATITIS C VIRUS IMMUNOGENIC COMPOSITIONS AND METHODS OF USE THEREOF
#25ADENOVIRAL GENE THERAPY VECTORS
#26METHODS OF TREATING SOLID OR LYMPHATIC TUMORS BY COMBINATION THERAPY
#27REPROGRAMMED FUNCTIONAL FRAGMENT OF RECOMBINANT ONCOLYTIC VIRUS, COMBINATION, AND APPLICATION THEREOF
#28VARIANT RNAi
#29MUTANT E1A ANTAGONIZING UBIQUITINATION-MEDIATED DEGRADATION AND ITS USE IN THE PREPARATION OF POTENTIATED ONCOLYTIC ADENOVIRUSES AND IMMUNE POTENTIATORS
#30USE OF p55-GAMMA GENE AND/OR p55-GAMMA PROTEIN AS TARGET IN MAINTAINING CARDIAC IRON HOMEOSTASIS AND TREATING RELATED DISEASE
#31VIRUS-DERIVED CONSTRUCT PLASMID LIBRARY AND CONSTRUCTION OF SAME
#32EXOGENOUS GENE CONTROLLABLE EXPRESSION VIRUS PACKAGING VECTOR AND PACKAGING METHOD
#33VIRAL DELIVERY OF NEOANTIGENS
#34VIRUS ENCODING TRANSGENES TO COMPLEMENT CELLULAR THERAPY
#35SYSTEMS AND METHODS FOR VIRAL TRANSFECTION OF CELLS IN A BIOREACTOR
#36ADENOVIRUS CONSTRUCTS AND METHODS OF USE
#37METHODS FOR INTRATUMORAL DELIVERY OF CRISPR/CAS SYSTEMS
#38USE OF p55gamma PROTEIN OR ENCODING GENE THEREOF AS TARGET IN PREPARATION OF DRUG FOR PREVENTING AND/OR TREATING VASCULAR CALCIFICATION
#39DUAL CHECKPOINT INHIBITORS AND METHODS OF USING THE SAME
#40MULTIPLEXED-TARGETED ADENOVIRUS VECTORS AND THEIR USE
#41VACCINE FOR USE IN THE PROPHYLAXIS AND/OR TREATMENT OF A DISEASE
#42REPROGRAMMING OF CELLS TO TYPE 1 CONVENTIONAL DENDRITIC CELLS OR ANTIGEN-PRESENTING CELLS
#43RECOMBINANT ADENOVIRUS VACCINE FOR AFRICAN SWINE FEVER AND METHOD FOR CONSTRUCTING SAME
#44COMPOSITIONS AND METHODS FOR INTERNALIZING ENZYMES
#45VACCINE COMPRISING NATURAL KILLER CELLS LOADED WITH LIGANDS OF NATURAL KILLER T CELLS AND CANCER ANTIGENS
#46ACTIVATION OF NONCODING HOST GENE LOCI
#47NUCLEIC ACID CONSTRUCTS ENCODING A CELL PENETRATING PEPTIDE, SIGNAL SEQUENCE AND TRANSCRIPTION FACTOR EB AND USES THEREOF
#48Virally Educated T cells
#49ADENOVIRAL EXPRESSION VECTOR AND METHODS AND CELL LINES FOR PRODUCTION
#50NOVEL IMMUNOSTIMULATING VECTOR SYSTEM
#51GLUCAGON-LIKE-PEPTIDE-2 (GLP-2) ANALOGUES
#52RIG1 Inhibition and Therapeutic Viral Protein Expression
#53COMPOSITIONS AND METHODS FOR TREATING BACTERIAL DISEASE
#54ANTICANCER COMPOSITION COMPRISING RECOMBINANT ADENOVIRUS EXPRESSING DEGRADATION FACTOR FOR EXTRACELLULAR MATRIX
#55ANTAGONISTIC ANTI-TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY POLYPEPTIDES
#56PD-L1 INHIBITORY PEPTIDE FOR CANCER IMMUNOTHERAPY
#57Method for Adenovirus Purification
#58MODIFIED U6 PROMOTER SYSTEM FOR TISSUE SPECIFIC EXPRESSION
#59SECRETED SPLICING VARIANT OF MAMMAL KLOTHO AS A MEDICAMENT FOR COGNITION AND BEHAVIOUR IMPAIRMENTS
#60VIRUS TO EXPRESS GAD65 UNDER E2 REGULATORY ELEMENT
#61An oncolytic virus vector coding for interleukin-7 (IL-7) polypeptide
#62ADENOVIRUSES AND METHODS FOR USING ADENOVIRUSES
#63NOVEL ADENOVIRUS VACCINE THERAPY FOR THE TREATMENT OF RECURRENT RESPIRATORY PAPILLOMATOSIS
#64SECRETED SPLICING VARIANT OF MAMMAL KLOTHO AS A MEDICAMENT FOR COGNITION AND BEHAVIOUR IMPAIRMENTS
#65CANCER-SPECIFIC TRANS-SPLICING RIBOZYME AS GENE THERAPY PRODUCT COMBINED WITH RADIOTHERAPY
#66VACCINE COMPOSITION FOR PREVENTION AGAINST COVID-19
#67NOVEL VACCINE FORMULATIONS FOR MYCOBACTERIUM TUBERCULOSIS AND USE OF THEREOF
#68BRACHYURY DELETION MUTANTS, NON-YEAST VECTORS ENCODING BRACHYURY DELETION MUTANTS, AND THEIR USE
#69METHOD FOR TREATING TUMOR WITH COMBINATION OF EXOGENOUS ANTIGEN AND THERAPEUTIC AGENT
#70TREATING DISEASES AND IMPROVING NUCLEIC ACID DELIVERY
#71ESTIMATION OF PHENOTYPES USING LARGE-EFFECT EXPRESSION VARIANTS
#72Ligand Binding Molecules and Uses Thereof
#73SELECTIVE STIMULATION OF T CELLS IN SOLID TUMORS USING ONCOLYTIC VIRAL DELIVERY OF ORTHOGONAL IL-2
#74ADENOVIRAL VECTORS AND VACCINES THEREOF
#75COMPOSITIONS AND METHODS FOR RECOMBINANT PARVOVIRUS PRODUCTION
#76STABILIZED PRE-FUSION RSV FB ANTIGENS
#77GENE THERAPY FOR OCULAR DISORDERS
#78METHODS AND COMPOSITIONS COMPRISING MHC CLASS I PEPTIDES
#79Pancreatic Islets as Protein Factories
#80Adenoviral Vectors
#81COMBINATION CANCER THERAPY
#82STABILIZED CORONAVIRUS SPIKE PROTEIN FUSION PROTEINS
#83ADENOVIRUS FOR TREATMENT OF CANCER
#84SARS-COV-2 VACCINE COMPOSITION AND USE THEREOF
#85Human Papilloma Virus Vaccines and Uses of the Same for HPV Associated Diseases
#86NUCLEIC ACIDS SIMULTANEOUSLY INHIBITING EXPRESSION OF C-MET GENE AND PD-L1 GENE
#87Vaccine for use in the prophylaxis and/or treatment of a disease
#88COMPOSITIONS AND METHODS FOR RECOMBINANT PARVOVIRUS PRODUCTION
#89STABILIZED PRE-FUSION RSV FB ANTIGENS
#90TEMPERATURE-RESPONSIVE VIRUS STORAGE SYSTEM
#91ADENOVIRAL GENE THERAPY VECTORS
#92HEK293T CELL STRAIN HAVING HIGH DISPERSIBILITY AND SCREENING METHOD THEREFOR
#93VIRAL DELIVERY OF NEOANTIGENS
#94METHODS FOR GENERATING HEMATOPOIETIC STEM CELLS AND COMPOSITIONS THEREOF
#95TEMPERATURE-RESPONSIVE VIRUS STORAGE SYSTEM
#96METHODS AND COMPOSITIONS COMPRISING TUMOR SUPPRESSOR GENE THERAPY FOR THE INHIBITION OF PATHOGENS
#97RECOMBINANT ONCOLYTIC VIRUSES, SURFACE-ENGINEERED DELIVERY SYSTEMS AND RELATED METHODS
#98Targeted neoepitope vectors and methods therefor
#99PREVENTION AND/OR TREATMENT OF HEARING LOSS OR IMPAIRMENT
#100VARIANT RNAi
#101COMPOSITIONS AND METHODS FOR RECOMBINANT PARVOVIRUS PRODUCTION
#102RECOMBINANT VIRUSES, SURFACE-ENGINEERED DELIVERY SYSTEMS AND RELATED METHODS
#103OPTIMIZATION OF ENGINEERED MEGANUCLEASES FOR RECOGNITION SEQUENCES
#104VISTA MODULATORS FOR DIAGNOSIS AND TREATMENT OF CANCER
#105ANTIGEN-ENCODING CASSETTES
#106Adenoviral Vectors Comprising Partial Deletions of E3
#107TREATMENT FOR ADVANCED COLORECTAL CARCINOMA
#108ENGINEERED ADENOVIRUS VECTORS AND USES THEREOF
#109VACCINE COMBINATION AGAINST REPIRATORY SYNCYTIAL VIRUS INFECTION
#110PRIME-BOOST REGIMENS INVOLVING ADMINISTRATION OF AT LEAST ONE mRNA CONSTRUCT
#111VIRAL VECTORS COMPRISING RDH12 CODING REGIONS AND METHODS OF TREATING RETINAL DYSTROPHIES
#112A VACCINE FOR USE IN THE PROPHYLAXIS AND/OR TREATMENT OF A DISEASE
#113TEMPERATURE-RESPONSIVE VIRUS STORAGE SYSTEM
#114METHODS FOR ENHANCING VASCULAR DENSITY
#115GENE EDITING METHODS FOR TREATING SPINAL MUSCULAR ATROPHY
#116Exogenous gene expression in recombinant adenovirus for minimal impact on viral kinetics
#117IL-2 SUPERAGONISTS IN COMBINATION WITH ANTI-PD-1 ANTIBODIES
#118Modified U6 promoter system for tissue specific expression
#119ONE-STEP METHOD FOR PRODUCING ADENOVIRAL VECTORS
#120GENE DELIVERY SYSTEM CONTAINING RELAXIN GENE AND PHARMACEUTICAL COMPOSITION USING RELAXIN
#121Methods of treating solid or lymphatic tumors by combination therapy
#122ADENOVIRAL ASSEMBLY METHOD
#123Vaccine for use in the prophylaxis and/or treatment of a disease
#124p63 inactivation for the treatment of heart failure
#125Vaccine for use in the prophylaxis and/or treatment of a disease
#126UNIVERSAL VACCINES AGAINST IMMUNOGENS OF PATHOGENIC ORGANISMS THAT PROVIDE ORGANISM-SPECIFIC AND CROSS-GROUP PROTECTION
#127Adeno-associated virus compositions for restoring F8 gene function and methods of use thereof
#128Constructs for Enhancing Immune Responses
#129TREATMENT METHODS USING ADENOVIRUS
#130Methods and Compositions for Treating Cancer
#131Helper-dependent adenoviral gene therapy delivery and expression system
#132RECOMBINANT ADENOVIRUS VACCINE FOR CORONA VIRUS DISEASE 19 AND COMBINATION THERAPY USING THE SAME
#133INDUCED ACTIVATION IN DENDRITIC CELLS
#134MODIFIED INTERLEUKIN 12 AND USE THEREOF IN PREPARING DRUGS FOR TREATING TUMOURS
#135Compositions And Methods For Viral Delivery Of Neoepitopes And Uses Thereof
#136Novel Method for Obtaining Efficient Viral Vector-Based Compositions for Vaccination or Gene Therapy
#137OPTIMIZATION OF ENGINEERED MEGANUCLEASES FOR RECOGNITION SEQUENCES
#138Compositions and methods for internalizing enzymes
#139ADENO-ASSOCIATED VIRAL VECTOR PRODUCER CELL LINES
#140COMPOSITIONS AND METHODS FOR IMPROVED GENE EDITING
#141COMBINATION IMMUNOTHERAPY
#142Immunogen for broad-spectrum influenza vaccine and application thereof
#143Hepatitis C virus immunogenic compositions and methods of use thereof
#144ISL1 and LHX3 VECTOR
#145Compositions and Methods for Inducing Protective Immunity Against Human Immunodeficiency Virus Infection
#146ONCOLYTIC ADENOVIRUS COMPOSITIONS
#147ADENOVIRUS LIBRARY AND METHODS
#148Combination therapy for treatment of thoracic cancer using Ad-REIC/Dkk-3 and a checkpoint inhibitor
#149Muscle-Specific Nucleic Acid Regulatory Elements and Methods and Use Thereof
#150Subcutaneous Delivery of Adenovirus with Dual Targeting
#151Brachyury deletion mutants, non-yeast vectors encoding brachyury deletion mutants, and their use
#152Adenoviral expression vector and methods and cell lines for production
#153Method for adenovirus purification
#154IMMUNE COMPOSITION, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF
#155NOVEL PROCESSES AND VACCINES
#156Compositions and methods for treating type 1 and type 2 diabetes and related disorders
#157MODIFIED SEROTYPE 28 ADENOVIRAL VECTORS
#158Rapid and prolonged immunologic-therapeutic
#159BIO-IMAGING PROBES AND METHODS FOR NON-INVASIVE DETECTION OF HUMAN UTERINE SARCOMAS
#160T-CELL INDUCING VACCINE COMPOSITION COMBINATION AND USES THEREOF
#161NUCLEOTIDE VACCINE
#162Immunostimulating vector system
#163FORMULATIONS FOR SIMIAN ADENOVIRAL VECTORS HAVING ENHANCED STABILITY
#164METHODS FOR DETERMINING THE PRESENCE OR RISK OF DEVELOPING FACIOSCAPULOHUMERAL DYSTROPHY (FSHD)
#165Viral vectors encoding cancer/testis antigens for use in a method of prevention or treatment of cancer
#166Prime/boost immunization regimen against HIV-1 utilizing a multiepitope T cell immunogen comprising Gag, Pol, Vif, and Nef epitopes
#167NEOEPITOPE VACCINE COMPOSITIONS AND METHODS OF USE THEREOF
#168Replication-enhanced oncolytic adenoviruses
#169COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY
#170Method of inactivating a glucocorticoid receptor gene in an isolated cell
#171Universal vaccines against immunogens of pathogenic organisms that provide organism-specific and cross-group protection
#172Adenoviral vectors comprising partial deletions of E3
#173Muscle-specific nucleic acid regulatory elements and methods and use thereof
#174Enhanced adoptive cell therapy
#175Antiviral vaccines with improved cellular immunogenicity
#176Enhancing T cell activation using altered MHC-peptide ligands
#177Recombinant human replication-deficient adenovirus comprising a modified nucleic acid encoding the Marburg virus envelope glycoprotein
#178Controlled Transgene Expression in Regulatory T Cells
#179Adenoviral Polypeptide IX Increases Adenoviral Gene Therapy Vector Productivity and Infectivity
#180Prevention and/or treatment of hearing loss or impairment
#181PSMA-based molecular-genetic reporter system
#182Rapid and prolonged immunogic therapeutic
#183Rapid and prolonged immunologic therapeutic
#184Exogenous gene expression in recombinant adenovirus for minimal impact on viral kinetics
#185Compositions and methods for viral delivery of neoepitopes and uses thereof
#186NEOEPITOPE VACCINE COMPOSITIONS AND METHODS OF USE THEREOF
#187Oncolytic adenoviral vector and methods of use
#188ANTAGONISTIC ANTI-TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY POLYPEPTIDES
#189NEOANTIGEN VACCINE COMPOSITION FOR TREATMENT OF CANCER
#190Variant RNAi
#191Method, system and recombinant bacmid for preparation of recombinant adeno-associated virus
#192ADENOVIRUS CONTROL VIRUS
#193Method for the safe induction of immunity against RSV
#194INDUCED ACTIVATION IN DENDRITIC CELLS
#195Brachyury deletion mutants, non-yeast vectors encoding Brachyury deletion mutants, and their use
#196Cell line for producing adenovirus and method of preparing the same
#197Ligand binding molecules and uses thereof
#198ADENOVIRAL ASSEMBLY METHOD
#199CRISPR/Cas 9-mediated integration of polynucleotides by sequential homologous recombination of AAV donor vectors
#200Gene therapy for ocular disorders
#201Method of inducing an immune response against human immunodeficiency virus by co-localized administration of vaccine components
#202Vista modulators for diagnosis and treatment of cancer
#203Targeted neoepitope vectors and methods therefor
#204Compositions and methods for inducing protective immunity against human immunodeficiency virus infection
#205Programmable Oncolytic Virus Vaccine System and Method
#206Adenovirus library and methods
#207VIRAL DELIVERY OF NEOANTIGENS
#208VIRAL METHODS OF MAKING GENETICALLY MODIFIED CELLS
#209Adenoviral vectors
#210Adenoviral vectors comprising partial deletions of E3
#211ANTICANCER COMPOSITION COMPRISING RECOMBINANT ADENOVIRUS EXPRESSING DEGRADATION FACTOR FOR EXTRACELLULAR MATRIX
#212METHODS FOR ENHANCING VASCULAR DENSITY
#213GENE DELIVERY SYSTEM CONTAINING RELAXIN GENE AND PHARMACEUTICAL COMPOSITION USING RELAXIN
#214Affenadenovirus (gorilla) or adenoviral vectors and methods of use
#215Adenoviral Polypeptide IX Increases Adenoviral Gene Therapy Vector Productivity and Infectivity
#216Antiviral vaccines with improved cellular immunogenicity
#217Adeno-associated virus compositions for restoring F8 gene function and methods of use thereof
#218Constructs for enhancing immune responses
#219Methods of treating cancer
#220Method for obtaining efficient viral vector-based compositions for vaccination or gene therapy
#221METHOD FOR AUGMENTING VISION IN PERSONS SUFFERING FROM PHOTORECEPTOR CELL DEGENERATION
#222Methods and materials for using butyrylcholinesterases to treat cancer
#223METHODS FOR INDUCING STEREOCILIA ON HAIR CELLS
#224Methods for inducing an immune response against human immunodeficiency virus infection in subjects undergoing antiretroviral treatment
#225Adenovirus formulations
#226Hepatitis c virus immunogenic compositions and methods of use thereof
#227Therapeutic HPV18 vaccines
#228Methods and compositions for inducing an immune response against Hepatitis B Virus (HBV)
#229ONCOLYTIC ADENOVIRUSES FOR CANCER TREATMENT
#230Compositions and methods for neurological diseases
#231VIRAL VECTORS COMPRISING RDH12 CODING REGIONS AND METHODS OF TREATING RETINAL DYSTROPHIES
#232Modified U6 promoter system for tissue specific expression
#233RAPID AND PROLONGED IMMUNOGENIC-THERAPEUTIC
#234PRODUCTION OF VIRAL VECTORS
#235Antigen for use in malaria
#236HERPES SIMPLEX VIRUS VACCINE
#237Subcutaneous Delivery of Adenovirus with Dual Targeting
#238METHODS AND COMPOSITIONS FOR ATTENUATING GENE EXPRESSION MODULATING ANTI-VIRAL TRANSFER VECTOR IMMUNE RESPONSES
#239Methods and compositions for treating cancer
#240Combination cancer therapy
#241Methods of treating bladder cancer by combination therapy comprising the oncolytic adenovirus CG0070 and an immune checkpoint inhibitor
#242IL-2 superagonists in combination with anti-PD-1 antibodies
#243Treatment methods using adenovirus
#244Immunostimulating vector system
#245Targets and compositions for use in decontamination, immunoprophylaxis, and post-exposure therapy against anthrax
#246METHODS AND MATERIALS FOR PRODUCING IMMUNE RESPONSES AGAINST POLYPEPTIDES INVOLVED IN ANTIBIOTIC RESISTANCE
#247Secreted splicing variant of mammal Klotho as a medicament for cognition and behaviour impairments
#248Treatment using truncated Trk B and Trk C antagonists
#249Methods for inducing migration by dendritic cells and an immune response
#250Modified interleukin 12 and use thereof in preparing drugs for treating tumours
#251Compositions and methods for viral delivery of neoepitopes and uses thereof
#252Exogenous gene expression in therapeutic adenovirus for minimal impact on viral kinetics
#253Compositions and methods for internalizing enzymes
#254Methods and compositions for combination immunotherapy
#255Engineered Cells Expressing Multiple Immunomodulators and Uses Thereof
#256MODULATION OF MICRORNA 184 TO TREAT PATHOLOGICAL LYMPHANGIOGENESIS
#257HER3 VACCINE VECTOR COMPOSITIONS AND METHODS OF USING THE SAME
#258CRISPR COMPOSITIONS AND METHODS OF USING THE SAME FOR GENE THERAPY
#259Methods for inducing protective immunity against human immunodeficiency virus infection
#260METHODS FOR TREATMENT OF CANCER
#261PRRSV minor protein-containing recombinant viral vectors and methods of making and use thereof
#262TARGETING MDA-5 ACTIVATION FOR CANCER IMMUNOTHERAPY
#263Adenovirus forumations
#264deletion mutants, non-yeast vectors encoding deletion mutants, and their use
#265Conjugates that are configured for targeted delivery of therapeutic compounds to senescent cells
#266Pharmaceutical composition comprising an adenoviral vector
#267Adenoviral vector encoding human atonal homolog-1 (HATH1)
#268Combination immunotherapy
#269Methods and compositions for combination immunotherapy
#270Methods to accelerate antibody diversification
#271Use of phospholipid scramblase inhibitors for modulating inflammatory immune responses
#272ARMED REPLICATION-COMPETENT ONCOLYTIC ADENOVIRUSES
#273TRIM11 for degradation of protein aggregates
#274Anti-tumor medicament based on adenovirus
#275AAV-mediated expression of anti-influenza antibodies and methods of use thereof
#276Prime-boost regimens involving administration of at least one mRNA construct
#277Smooth muscle specific inhibition for anti-restenotic therapy
#278Modified serotype 28 adenoviral vectors
#279SAB as a biomarker for degenerative diseases and therapeutic sensitivity in cancers
#280Combination immunotherapy for treating cancer
#281Affenadenovirus (gorilla) or adenoviral vectors and methods of use
#282p63 inactivation for the treatment of heart failure
#283Methods for inducing an immune response against human immunodeficiency virus infection in subjects undergoing antiretroviral treatment
#284Prevention and/or treatment of hearing loss or impairment
#285Therapeutic miRNAs for treating heart and skeletal muscle diseases
#286METHODS AND COMPOSITIONS FOR TREATING GLAUCOMA
#287Therapeutic HPV18 vaccines
#288Human adenovirus serotype 5 vectors containing E1 and E2B deletions encoding the ebola virus glycoprotein
#289Multitargeting onocolytic adenovirus, methods of use, and methods of making
#290Ligand binding molecules and uses thereof
#291Contructs for enhancing immune responses
#292LncRNA and oncolytic adenovirus, and application thereof
#293Method for selectively inhibiting ACAT1 in the treatment of neurodegenerative diseases
#294Muscle-specific nucleic acid regulatory elements and methods and use thereof
#295Herpes simplex virus vaccine
#296Virus-PCION complex having enhanced antitumor effect by using electromagnetic field
#297Antiviral vaccines with improved cellular immunogenicity
#298Regeneration of Inner Ear Cells
#299Antigen for use in malaria
#300PSMA-based molecular-genetic reporter system